SEARCH

SEARCH BY CITATION

References

  • Adjuik M, Agnamey P, Babiker A et al. (2002) Amodiaquine-artesunate versus amodiaquine for uncomplicated Plasmodium falciparum malaria in African children: a randomized, multicentre trial. Lancet 359, 13651372.
  • Anonymous (1994) Epi Info Version 6. A Word Processing Data Base and Statistics Program for Public Health on IBM-compatible Microcomputers. Centers for Disease Control and Prevention, Atlanta, GA.
  • Basco LK, Same-Ekobo A, Ngane VF et al. (2002) Therapeutic efficacy of sulfadoxine-pyrimethamine, amodiaquine and the sulfadoxine-pyrimethamine-amodiaquine combination against uncomplicated Plasmodium falciparum malaria in young children in Cameroon. Bulletin of the World Health Organization 80, 538545.
  • Bloland PB, Ettling M & Meek S (2000) Combination therapy for malaria in Africa: hype or hope? Bulletin of the World Health Organization 78, 13781388.
  • Bloland PB (2003) A contrarian view of malaria therapy policy in Africa. American Journal of Tropical Medicine and Hygiene 68, 125126.
  • Bojang KA, Schneider G, Forck S et al. (1998) A trial of Fansidar plus chloroquine or Fansidar alone for the treatment of uncomplicated malaria in Gambian children. Transactions of the Royal Society of Tropical Medicine and Hygiene 92, 7376.
  • Cooper RA & Bunn HF (1991) Hemolytic anemias. In: Harrison's: Principles of Internal Medicine, Vol. 2 (eds WilsonJD, BraunwaldE, IsselbacherKJ, PetersdorfRG, MartinJB, FauciAS & RootRK) McGraw-Hill, New York, pp. 15311543.
  • Drakeley CJ, Jawara M, Targett GAT et al. (2003) Addition of artesunate to chloroquine for the treatment of P. falciparum malaria in Gambian children causes a significant but short-lived reduction in infectiousness for mosquitoes. Tropical Medicine and International Health 9, 5361.
  • Ekanem OJ, Weisfeld JS, Salako LA et al. (1987) Sensitivity of Plasmodium falciparum to chloroquine and sulphadoxinepyrimethamine in Nigerian children. Bulletin of the World Health Organization 68, 4552.
  • Gasasira AF, Dorsey G, Nzarubara B et al. (2003) Comparative efficacy of aminoquinoline-antifolate combinations for the treatment of uncomplicated falciparum malaria in Kampala, Uganda. American Journal of Tropical Medicine and Hygiene 68, 127132.
  • Happi TC, Thomas SM, Gbotosho GO et al. (2003) Point mutations in the pfcrt and pfmdr-1 genes of Plasmodium falciparum and clinical response to chloroquine, among malaria patients from Nigeria. Annals of Tropical Medicine and Parasitology 97, 439451.
  • Happi TC, Gbotosho GO, Sowunmi A et al. (2004) Molecular analysis of Plasmodium falciparum recrudescent malaria infections in children treated with chloroquine in Nigeria. American Journal of Tropical Medicine and Hygiene 70, 2026.
  • Hatton C, Peto T, Bunch C et al. (1986) Frequency of severe neutropenia associated with amodiaquine prophylaxis against malaria. Lancet i, 411413.
  • Hugosson E, Tarimo D, Troye-Bloomberg M, Montgomery SM, Premji Z & Björkmann A (2003) Antipyretic, parasitologic, and immunologic effects of combining sulfadoxine/pyrimethamine with chloroquine or paracetamol for treating uncomplicated Plasmodium falciparum malaria. American Journal of Tropical Medicine and Hygiene 69, 366371.
  • Ochong EO, Van Den Broek IVF, Keus K & Nzila A (2003) Short report: association between chloroquine and amodiaquine resistance and allelic variation in the Plasmodium falciparum multiple drug resistance 1 gene and the chloroquine resistance transporter gene in isolates from the Upper Nile in southern Sudan. American Journal of Tropical Medicine and Hygiene 69, 184187.
  • Oduola AMJ, Sowunmi A, Milhous WK et al. (1992) Innate resistance to new antiamalarial drugs in Plasmodium falciparum from Nigeria. Transactions of the Royal Society of Tropical Medicine and Hygiene 86, 123126.
  • Pitmang SL, Thacher TD, Madaki JKA, Egah DZ & Fischer PR (2005) Comparison of sulfadoxine-pyrimethamine with and without chloroqunie for uncomplicated malaria in Nigeria. American Journal of Tropical Medicine and Hygiene 72, 263266.
  • Price RN, Nosten F, Luxemburger C et al. (1996) Effects of artemisinin derivatives on malaria transmissibility. Lancet 347, 16541658.
  • Puta C & Manyando C (1997) Enhanced gametocyte production in Fansidar-treated Plasmodium falciparum malaria patients: implications for malaria transmission control programmes. Tropical Medicine and International Health 2, 227229.
  • Robert V, Awono-Ambene HP, Le Hesran J-Y & Trape J-F (2000) Gametocytaemia and infectivity to mosquitoes of patients with uncomplicated Plasmodium falciparum malaria attacks treated with chloroquine or sulfadoxine-pyrimethamine. American Journal of Tropical Medicine and Hygiene 62, 210216.
  • Salako LA, Ajayi FO, Sowunmi A & Walker O (1990) Malaria in Nigeria: a revisit. Annals of Tropical Medicine and Parasitology 84, 435445.
  • Schwobel B, Jordan S, Vanisaveth V et al. (2003) Therapeutic efficacy of chloroquine plus sulphadoxine/pyrimethamine compared with monotherapy with either chloroquine or sulphadoxine/pyrimethamine in uncomplicated Plasmodium falciparum malaria in Laos. Tropical Medicine and International Health 8, 1924.
  • Sibley CH, Hyde JE, Sims PFG et al. (2001) Pyrimethamine-sulfadoxine resistance in Plasmodium falciparum: what next? Trends in Parasitology 17, 582588.
  • Sowunmi A & Salako LA (1992) Evaluation of the relative efficacy of various antimalarial drugs in Nigerian children under five years of age suffering from acute uncomplicated falciparum malaria. Annals of Tropical Medicine and Parasitology 86, 18.
  • Sowunmi A, Oduola AMJ, Ogundahunsi OAT et al. (1998) Randomised trial of artemether versus artemether and mefloquine for the treatment of chloroquine/sulfadoxine-pyrimethamine-resistant falciparum malaria during pregnancy. Journal of Obstetrics & Gynaecology 18, 322327.
  • Sowunmi A, Sowunmi CO, Adedeji AA & Oduola AMJ (2001) Comparison of artemether and artemether plus mefloquine in children with malaria and effects on viability of Plasmodium falciparum ex vivo. Clinical Drug Investigation 21, 3340.
  • Sowunmi A (2002) A randomized comparison of chloroquine, amodiaquine and their combination with pyrimethamine-sulfadoxine in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Annals of Tropical Medicine and Parasitology 96, 227238.
  • Sowunmi A (2003) A randomized comparison of chloroquine, and chloroquine plus ketotifen in the treatment of acute, uncomplicated, Plasmodium falciparum malaria in children. Annals of Tropical Medicine and Parasitology 97, 107117.
  • Sowunmi A & Fateye BA (2003) Plasmodium falciparum gametocytaemia in Nigerian children: before, during and after treatment with antimalarial drugs. Tropical Medicine and International Health 8, 783792.
  • Sowunmi A, Fehintola FA, Adedeji AA et al. (2004a) Open randomized study of pyrimethamine-sulphadoxine vs. pyrimethamine-sulphadoxine plus probenecid for the treatment of uncomplicated Plasmodium falciparum malaria in children. Tropical Medicine & International Health 9, 606614.
  • Sowunmi A, Fateye BA, Adedeji AA, Fehintola FA & Happi TC (2004b) Risk factors for gametocyte carriage in uncomplicated falciparum malaria in children. Parasitology 129, 255262.
  • Talisuna AO, Nalunkuma-Kazibwe A, Bakyaita N et al. (2004) Efficacy of sulphadoxine-pyrimethamine alone or combined with amodiaquine or chloroquine for the treatment of uncomplicated falciparum malaria in Ugandan children. Tropical Medicine and International Health 9, 222229.
  • Targett G, Drakeley C, Jawara M et al. (2001) Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiae. Journal of Infectious Diseases 183, 12541259.
  • Tjitra E, Suprianto S & Anstey NM (2002) Higher gametocyte prevalence following failure of treatment of Plasmodium falciparum malaria with sulfadoxine-pyrimethamine and the combination of chloroquine plus sulfadoxine-pyrimethamine: implications for progression of anti-folate resistance. Transactions of the Royal Society of Tropical Medicine and Hygiene 96, 434437.
  • Trape J-F, Pison G, Preziosi M-P et al. (1998) Impact of chloroquine resistance on malaria mortality. Life Sciences 321, 689697.
  • Trape JF (2001) The public health impact of chloroquine resistance in Africa. American Journal of Tropical Medicine and Hygiene 64 (Suppl. 1–2), 1217.
  • von Seidlein L, Milligan P, Pinder M et al. (2000) Efficacy of artesunate plus pyrimethamine-sulfadoxine for uncomplicated malaria in Gambian children. Lancet 355, 352357.
  • von Seidlein L, Drakeley C, Greenwood B, Walraven G & Targett G (2001a) Risk factors for gametocyte carriage in Gambian children. American Journal of Tropical Medicine and Hygiene 65, 523527.
  • von Seidlein L, Jawara M, Coleman R, Doherty T, Walraven G & Targett G (2001b) Parasitaemia and gametocytaemia after treatment with chloroquine, pyrimethamine/sulfadoxine, and pyrimethamine/sulfadoxine combined with artesunate in young Gambians with uncomplicated malaria. Tropical Medicine and International Health 6, 9298.
  • World Health Organization (1973) Chemotherapy of Malaria and Resistance to Antimalarials. Technical Report Series No. 529. WHO, Geneva.
  • World Health Organization (2000) Severe falciparum malaria . Transactions of the Royal Society of Tropical Medicine and Hygiene 94 (Suppl. 1) 190.
  • World Health Organization (2001) Antimalarial Drug Combination Therapy. Report of a WHO Technical Consultation. (WHO/CDS/RBM/2001.35) WHO, Geneva.
  • World Health Organization (2003) Asssessment and Monitoring of Antimalarial Drug Efficacy for the Treatment of Uncomplicated Falciparum Malaria. (WHO/HTM/RBM/2003.50) WHO, Geneva.